Statistics
Total Visits
| Views | |
|---|---|
| Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2 | 202 |
Total Visits Per Month
| December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | June 2026 | |
|---|---|---|---|---|---|---|---|
| Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2 | 2 | 16 | 13 | 10 | 14 | 17 | 0 |
File Visits
| Views | |
|---|---|
| Barreiro_Preclinical_2023.pdf | 5 |
Top country views
| Views | |
|---|---|
| Singapore | 39 |
| United States | 30 |
| Spain | 16 |
| Brazil | 15 |
| China | 7 |
| Germany | 7 |
| Argentina | 4 |
| Nepal | 3 |
| Ukraine | 3 |
| South Africa | 3 |
Top cities views
| Views | |
|---|---|
| Singapore | 23 |
| Caldes de Montbui | 11 |
| Beijing | 4 |
| Los Angeles | 3 |
| Frankfurt am Main | 2 |
| Nuremberg | 2 |
| São Paulo | 2 |
| Vienna | 2 |
| Amman | 1 |
| Andradina | 1 |